Thomas M. Cunningham

Array ( [id] => 3450689 [patent_doc_number] => 05385888 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-01-31 [patent_title] => 'Class I MHC modulation or surface receptor activity' [patent_app_type] => 1 [patent_app_number] => 8/057184 [patent_app_country] => US [patent_app_date] => 1993-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11890 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/385/05385888.pdf [firstpage_image] =>[orig_patent_app_number] => 057184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2996557 [patent_doc_number] => 05370871 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-12-06 [patent_title] => 'Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry' [patent_app_type] => 1 [patent_app_number] => 8/049601 [patent_app_country] => US [patent_app_date] => 1993-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 12761 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/370/05370871.pdf [firstpage_image] =>[orig_patent_app_number] => 049601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3985772 [patent_doc_number] => 05891435 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Methods and compositions for delaying or preventing the onset of autoimmune disease' [patent_app_type] => 1 [patent_app_number] => 8/048979 [patent_app_country] => US [patent_app_date] => 1993-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8349 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/891/05891435.pdf [firstpage_image] =>[orig_patent_app_number] => 048979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3629556 [patent_doc_number] => 05609872 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-11 [patent_title] => 'Peptides comprising a protective epitope from blood stages of plasmodium falciparum' [patent_app_type] => 1 [patent_app_number] => 7/969305 [patent_app_country] => US [patent_app_date] => 1993-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 7610 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/609/05609872.pdf [firstpage_image] =>[orig_patent_app_number] => 969305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3552029 [patent_doc_number] => 05573943 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-12 [patent_title] => 'Cloning and expression of a rhoptry associated protein of P. falciparum' [patent_app_type] => 1 [patent_app_number] => 7/971759 [patent_app_country] => US [patent_app_date] => 1993-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 7963 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/573/05573943.pdf [firstpage_image] =>[orig_patent_app_number] => 971759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4098510 [patent_doc_number] => 06051225 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-18 [patent_title] => 'Family of high affinity, modified antibodies for cancer treatment' [patent_app_type] => 1 [patent_app_number] => 8/040687 [patent_app_country] => US [patent_app_date] => 1993-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 64 [patent_figures_cnt] => 46 [patent_no_of_words] => 42508 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/051/06051225.pdf [firstpage_image] =>[orig_patent_app_number] => 040687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3712586 [patent_doc_number] => 05671848 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-30 [patent_title] => 'Kit for the diagnosis of insulin dependent diabetes mellitus' [patent_app_type] => 1 [patent_app_number] => 8/039704 [patent_app_country] => US [patent_app_date] => 1993-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8306 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/671/05671848.pdf [firstpage_image] =>[orig_patent_app_number] => 039704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3045932 [patent_doc_number] => 05324510 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-06-28 [patent_title] => 'Use of antibodies to intercellular adhesion molecule-1 (ICAM-1) in the treatment of asthma' [patent_app_type] => 1 [patent_app_number] => 8/037461 [patent_app_country] => US [patent_app_date] => 1993-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 9 [patent_no_of_words] => 14524 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/324/05324510.pdf [firstpage_image] =>[orig_patent_app_number] => 037461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3616235 [patent_doc_number] => 05614192 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-25 [patent_title] => 'T cell receptor peptides as therapeutics for immune-related disease' [patent_app_type] => 1 [patent_app_number] => 8/059020 [patent_app_country] => US [patent_app_date] => 1993-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 47 [patent_no_of_words] => 54108 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/614/05614192.pdf [firstpage_image] =>[orig_patent_app_number] => 059020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3429383 [patent_doc_number] => 05403919 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-04-04 [patent_title] => 'Method to control leukocyte extravasation' [patent_app_type] => 1 [patent_app_number] => 8/034791 [patent_app_country] => US [patent_app_date] => 1993-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7610 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/403/05403919.pdf [firstpage_image] =>[orig_patent_app_number] => 034791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3058891 [patent_doc_number] => 05310551 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-05-10 [patent_title] => 'Method for inhibiting pulmonary oxygen toxicity' [patent_app_type] => 1 [patent_app_number] => 8/015744 [patent_app_country] => US [patent_app_date] => 1993-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3710 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/310/05310551.pdf [firstpage_image] =>[orig_patent_app_number] => 015744 [rel_patent_id] =>[rel_patent_doc_number] =>)